> Shares of Arrowhead ($ARWR) dropped over 8% with news that Novartis would be closing a large portion of its RNAi research arm in Boston, according to Street Register. Brief
> Swedish Nordic Capital is said to be a leading bidder for LTS Lohmann Therapie-Systeme, a German nicotine patch maker, according to a report in Bloomberg BusinessWeek. Story
> Moberg Pharma inked a deal with Oracain II Aps for global rights to its oral formulation of bupivacaine to treat pain in the oral cavity. Release
> IntelGenx ($IGXT) snagged a patent for its AdVersa mucoadhesive drug delivery technology. More